Smoking and the results of percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction (according to the data of Tyumen cardiology research center register)
I.S. Bessonov, V.A. Kuznetsov, I.P. Zyryan ov, G.S. Pushkarev
The aim of this study was to evaluate the effect of smoking on the results of percutaneous coronary interventions (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).
keywords: myocardial infarction, smoking, primary percutaneous coronary interventions
for references: I.S. Bessonov, V.A. Kuznetsov, I.P. Zyryanov, G.S. Pushkarev. Smoking and the Results of Percutaneous Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction (according to the data of Tyumen Cardiology Research Center register). Emergency Cardiology and Cardiovascular Risks. 2018, vol. 2, № 2, pp. 323-327
[1] Amirov N.B., Andreyeva T.I Tabachnaya ehpidemiya: farmakologicheskie vozmozhnosti bor’by [The tobacco epidemic: pharmacological control features]. Vestnik sovremennoj klinicheskoj meditsiny, 2011, vol. 4, № 3, pp. 28-33. (in Russian).
[2] Sharafeev A.Z., Malov A.A., Alkhazurov A.I., Khalirakhmanov A.F., Gabdulkhakov E.F. Osobennosti reperfuzionnogo povrezhdeniya miokarda u kuril’shhikov vo vremya ostrogo infarkta miokarda po dannym MRT [The features of m yocardium reperfusion in smokers in acute myocardial infarction according to MRI]. Vestnik sovremennoj klinicheskoj meditsiny, 2018, vol. 11, № 3, pp. 76-81. doi: 10.20969/VSKM .2018.11(3). (in Russian).
[3] Kelly T.L., Gilpin E., Ahnve S., Henning H., Ross J Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J, 1985, vol. 110, № 3, pp. 535-541. doi:https://doi.org/10.1016/0002- 8703(85)90071-7.
[4] Barbash G.I., Reiner J., White H.D., Wilcox R.G., Armstrong P.W., Sadowsi Z., Morris D., Aylward P., Woodlief L.H., Topol E.J. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the «smoker’s paradox» from the GUSTO-I trial, with angiographic insights. J Am Coll Cardiol. 1995, vol. 26, № 5, pp. 1222-1229. doi: 10.1016/0735-1097(95)00299-5.
[5] Neumann F.J., Sousa-Uva M., Ahlsson A., Alfonso F., Banning A.P., Benedetto U., Byrne R.A., Collet J.P., Falk V., Head S.J., Juni P., Kastrati A., Koller A., Kristensen S.D., Niebauer J., Richter D.J., Seferovic P.M., Sibbing D., Stefanini G.G., Windecker S., Yadav R., Zembala M.O. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J, 2018, Aug 25, pp. 1-96. doi:10.1093/eurheartj/ehy394.
[6] Kuznetsov V.A., Yaroslavskaya V.I., Pushkarev G.S., Zyryanov I.P., Bessonov I.S., Gorbatenko E.A., Nyamtsu A.M. Vzaimosvyaz’ chreskozhnykh koronarnykh vm eshatel’stv pri ostrykh form akh ishem icheskoj bolezni serdtsa i pokazatelej smertnosti naseleniya Tyumenskoj oblasti [Interrelation of percutaneous coronary interventions in acute forms of coronary heart disease and death rates of the population of the Tyumen region]. Rossijskij kardiologicheskijzhurnal, 2014, vol. 19, № 6, pp.42-46. (in Russian).
[7] Jaffe R., Charron T., Puley G., Dick A., Strauss B.H. M icrovascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation, 2008, vol. 117, № 24, pp. 3152-3156. doi: 10.1161/circulationaha.107.742312
[8] Rakowski T., Siudak Z., Dziewierz A., Dubiel J. S., Dudek D. Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with prim ary percutaneous coronary intervention. J Thromb Thrombolysis, 2012, vol. 34, № 3, pp. 397-403.
[9] Zyryanov I.P., Bessonov I.S., Kuznetsov V.A., Sapozhnikov S.S., Gorbatenko E.A. Chreskozhnye koronarnye vmeshatel’stva u patsientov s ostrym koronarnym sindromom v razlichnykh vozrastnykh gruppakh [Percutaneous coronary interventions in patients with acute coronary syndrome in different age groups]. Int J Intervent Cardioangiol, 2013, № 35, p. 46. (in Russian).
[10] Gennaro G., Brener S.J., Redfors B., Kirtane A.J., Genereux P., Maehara A., Neunteufl T., Metzger D.C., Mehran R., Gibson C.M., Stone G.W. Effect of smoking on infarct size and major adverse cardiac events in patients with large anterior ST-elevation myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol, 2016, vol. 118, № 8, pp. 1097-1104. doi: https:// doi.org/10.1016/j.amjcard.2016.07.019.
[11] Saad M., Fuernau G., Desch S., Eitel I., Jung C., Poss J., Schneider S., Schuler G., Werdan K., Zeymer U., Thiele H. «Smoker’s paradox» in patients with cardiogenic shock complicating myocardial infarction-A substudy of the IABP-SHOCK II-trial and registry. Int J Cardiol, 2016, № 222, pp. 775-779. doi: 10.1016/j.ijcard.2016.07.172.
[12] Haig C., Carrick D., Carberry J., Mangion K., Maznyczka A., Wetherall K., McEntegart M., Petrie M.C., Eteiba H., Lindsay M., Hood S., Watkins S., Davie A., Mahrous A., M ordi I., Ahmed N., Teng Yue May V., Ford I., Radjenovic A., Welsh P., Sattar N., Oldroyd K.G., Berry C. Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights. JACC Cardiovasc Imaging, 2018, Jul 13. pii: S1936-878X(18)30512-6. doi: 10.1016/j.jcmg.2018.05.022.
[13] Sharma S.P., Dahal K., Rijal J., Fonarow G.C. Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary Intervention. Am J Cardiol, 2018, Jun 25. pii: S0002-9149(18)31246-3. doi: 10.1016/j.amjcard.2018.05.045.
[14] Symons R., Masci P.G., Francone M., Claus P., Barison A., Carbone I., Agati L., Galea N., Janssens S., Bogaert J. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker’s paradox revisited. Eur Heart J, 2016, vol. 37, № 36, pp. 2756-2764. doi: https://doi.org/10.1093/eurheartj/ehv738.
